SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-15-129600
Filing Date
2015-04-14
Accepted
2015-04-14 17:29:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 424B4 d909968d424b4.htm 424B4 508210
2 GRAPHIC g895439dsp_044a.jpg GRAPHIC 53158
3 GRAPHIC g895439dsp_044b.jpg GRAPHIC 46245
4 GRAPHIC g895439dsp_044c.jpg GRAPHIC 18148
5 GRAPHIC g895439dsp_044d.jpg GRAPHIC 19763
6 GRAPHIC g895439dsp_044e.jpg GRAPHIC 44816
7 GRAPHIC g895439pc_pg01.jpg GRAPHIC 8102
8 GRAPHIC g909968logo.jpg GRAPHIC 11073
  Complete submission text file 0001193125-15-129600.txt   787808
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-187508 | Film No.: 15770053
SIC: 2835 In Vitro & In Vivo Diagnostic Substances